U.S. Patent Office Revises Guidelines After Drugmakers Complain

by jeeg 17. December 2014 23:55
  After months of complaints from the pharmaceutical industry, the U.S. Patent and Trademark Office has issued revised guidelines for its examiners that should make it easier for drug makers and biotechs to obtain patents for their inventions. In general, the new guidelines take what the ag... [More]

Gene patents put patients at risk

by jeeg 28. March 2013 19:35
Authorities have gone too far in allowing claims on DNA   For more than 30 years legal authorities around the world have been arguing about the patentability of DNA. The next round takes place on April 15 when the US Supreme Court hears a challenge to patents held by Myriad Genetics ... [More]
Log in